Dr Reddy’s Knocked Back On Rituximab In US

Biosimilar Rival To Rituxan Receives Complete Response Letter From FDA

 
• By David Wallace
Stop sign in front of US flag
Approval of Dr Reddy’s rituximab has been blocked in the US • Source: Shutterstock

More from Biosimilars

More from Products